Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Jun. 2026,
Asker Healthcare Group AB paidkr0 Mil more to buy back shares than it received from issuing new shares.
It receivedkr389 Mil from issuing more debt.
It paidkr0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spentkr149 Mil paying cash dividends to shareholders.
It spentkr3 Mil on other financial activities.
In all, Asker Healthcare Group ABearnedkr237 Mil on financial activities for the
three
months ended in Jun. 2026.
Asker Healthcare Group AB (OSTO:ASKER) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Asker Healthcare Group AB's issuance of stock for the
three
months ended in Jun. 2026 was kr0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Asker Healthcare Group AB's repurchase of stock for the
three
months ended in Jun. 2026 was kr0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Asker Healthcare Group AB's net issuance of debt for the
three
months ended in Jun. 2026 was kr389 Mil.
Asker Healthcare Group AB receivedkr389 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Asker Healthcare Group AB's net issuance of preferred for the
three
months ended in Jun. 2026 was kr0 Mil.
Asker Healthcare Group AB paidkr0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Asker Healthcare Group AB's cash flow for dividends for the
three
months ended in Jun. 2026 was kr-149 Mil.
Asker Healthcare Group AB spentkr149 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Asker Healthcare Group AB's other financing for the
three
months ended in Jun. 2026 was kr-3 Mil.
Asker Healthcare Group AB spentkr3 Mil on other financial activities.
Asker Healthcare Group AB Cash Flow from Financing Related Terms
Asker Healthcare Group AB Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Asker Healthcare Group AB's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asker Healthcare Group AB Cash Flow from Financing Chart
Asker Healthcare Group AB Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Asker Healthcare Group AB's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr259 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of kr259 Mil mean?
Asker Healthcare Group AB (OSTO:ASKER) has a Cash Flow from Financing of kr259 Mil as of Jun. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Asker Healthcare Group AB and its competitors.
Is Asker Healthcare Group AB's Cash Flow from Financing too high?
Asker Healthcare Group AB's current Cash Flow from Financing is kr259 Mil. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's Cash Flow from Financing compare to MCK and COR?
Asker Healthcare Group AB's Cash Flow from Financing of kr259 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Medical Distribution company?
A good Cash Flow from Financing depends on the Medical Distribution industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Asker Healthcare Group AB and its competitors. Asker Healthcare Group AB's current Cash Flow from Financing is kr259 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current Cash Flow from Financing of kr259 Mil. The current Cash Flow from Financing is kr259 Mil. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current Cash Flow from Financing is kr259 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score
Get the complete analysis for OSTO:ASKER
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ASKER has been successfully added to your 
